These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17540423)

  • 21. Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery.
    Naslund M; Eaddy MT; Hogue SL; Kruep EJ; Shah MB
    Curr Med Res Opin; 2009 Nov; 25(11):2663-9. PubMed ID: 19757985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Familial clustering of obesity and the role of lifestyle factors among children in Beijing].
    Xi B; Mi J; Duan JL; Yan SJ; Cheng H; Hou DQ; Zhao XY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Feb; 43(2):122-7. PubMed ID: 19534904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian rhythm of blood pressure in patients with benign prostatic hyperplasia.
    Turgut F; Bayrak O; Kanbay M; Ozkara A; Uz E; Bavbek N; Kargili A; Akcay A
    Scand J Urol Nephrol; 2008; 42(1):47-52. PubMed ID: 17853012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical questionnaires about benign prostatic hyperplasia].
    Zhang XH; Li X; Ye ZQ; Sun ZY; Sun YH; Sun G; Wang JY; Na YQ
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1153-5. PubMed ID: 19094678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incontinence related to management of benign prostatic hypertrophy.
    Han E; Black LK; Lavelle JP
    Am J Geriatr Pharmacother; 2007 Dec; 5(4):324-34. PubMed ID: 18179990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transurethral resection of the prostate (TURP)--in the treatment of benign prostatic hypertrophy (BPH) in Mekelle, Ethiopia.
    Alemu MH
    Ethiop Med J; 2009 Jan; 47(1):65-9. PubMed ID: 19743783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevalence of benign hypertrophy of the prostate in Turkish men hospitalized in urology].
    Oztürk A; Serel TA; Kosar A; Kecelioglu M
    Prog Urol; 2000 Sep; 10(4):568-70. PubMed ID: 11064898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial.
    Barkin J; Roehrborn CG; Siami P; Haillot O; Morrill B; Black L; Montorsi F;
    BJU Int; 2009 Apr; 103(7):919-26. PubMed ID: 19239460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Who works in the prevention and early detection of benign prostatic hyperplasia and prostate cancer in Croatia?].
    Kranjcević K; Marković BB
    Acta Med Croatica; 2007 Feb; 61(1):45-8. PubMed ID: 17593640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
    Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
    Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of benign prostatic hyperplasia in general practice and practical approach of the Tunisian general practitioner (Prevapt study)].
    Horchani A; Binous MY; Ben Hamida A; Sallami S; El Adbi H; Naji A
    Tunis Med; 2007 Aug; 85(8):619-24. PubMed ID: 18254279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for gastric cancer in South India.
    Sumathi B; Ramalingam S; Navaneethan U; Jayanthi V
    Singapore Med J; 2009 Feb; 50(2):147-51. PubMed ID: 19296029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for benign prostatic hyperplasia in South Korean men.
    Hong J; Kwon S; Yoon H; Lee H; Lee B; Kim HH; Jeong EK; Park H
    Urol Int; 2006; 76(1):11-9. PubMed ID: 16401915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between lower urinary tract symptoms and objective measures of benign prostatic hyperplasia: a Chinese survey.
    Wang JY; Liu M; Zhang YG; Zeng P; Ding Q; Huang J; He DL; Song B; Kong CZ; Pang J
    Chin Med J (Engl); 2008 Oct; 121(20):2042-5. PubMed ID: 19080272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Onion and garlic intake and the odds of benign prostatic hyperplasia.
    Galeone C; Pelucchi C; Talamini R; Negri E; Dal Maso L; Montella M; Ramazzotti V; Franceschi S; La Vecchia C
    Urology; 2007 Oct; 70(4):672-6. PubMed ID: 17991535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
    Fourcade RO; Théret N; Taïeb C;
    BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
    Jordan SJ; Green AC; Whiteman DC; Webb PM;
    Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of interleukin-4 and interleukin-1 receptor antagonist gene polymorphisms and risk of benign prostatic hyperplasia.
    Konwar R; Gara R; Singh M; Singh V; Chattopadhyay N; Bid HK
    Urology; 2008 May; 71(5):868-72. PubMed ID: 18455629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.
    Ikuerowo SO; Akindiji YO; Akinoso OA; Akinlusi FM; Esho JO
    Urol Int; 2008; 80(3):296-9. PubMed ID: 18480635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.